One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F15%3A43910459" target="_blank" >RIV/00216208:11120/15:43910459 - isvavai.cz</a>

Výsledek na webu

<a href="http://circinterventions.ahajournals.org/content/8/12/e002933.abstract" target="_blank" >http://circinterventions.ahajournals.org/content/8/12/e002933.abstract</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1161/CIRCINTERVENTIONS.115.002933" target="_blank" >10.1161/CIRCINTERVENTIONS.115.002933</a>

Jazyk výsledku

angličtina

Název v původním jazyce

One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study

Popis výsledku v původním jazyce

BACKGROUND: Bioresorbable vascular scaffolds (BVS) represent promising new technology, but data on their long-term outcomes in ST-segment-elevation myocardial infarction (STEMI) setting are missing. The aim was to analyze 1-year clinical and computed tomographic angiographic outcomes after BVS implantation in STEMI. METHODS AND RESULTS: PRAGUE-19 is a prospective multicenter single-arm study enrolling consecutive STEMI patients undergoing primary percutaneous coronary intervention (pPCI) with intention-to-implant BVS. A total of 343 STEMI patients were screened during 15 months enrollment period, and 70 patients (mean age 58.6+-10.3 and 74% males) fulfilled entry criteria and BVS was successfully implanted in 96% of them. All patients were invited forclinical and computed tomographic angiographic control 1 year after BVS implantation. Restenosis was defined as GREATER-THAN OR EQUAL TO75% area stenosis within the scaffolded segment. Three events were potentially related to BVS: 1 in-st

Název v anglickém jazyce

One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study

Popis výsledku anglicky

BACKGROUND: Bioresorbable vascular scaffolds (BVS) represent promising new technology, but data on their long-term outcomes in ST-segment-elevation myocardial infarction (STEMI) setting are missing. The aim was to analyze 1-year clinical and computed tomographic angiographic outcomes after BVS implantation in STEMI. METHODS AND RESULTS: PRAGUE-19 is a prospective multicenter single-arm study enrolling consecutive STEMI patients undergoing primary percutaneous coronary intervention (pPCI) with intention-to-implant BVS. A total of 343 STEMI patients were screened during 15 months enrollment period, and 70 patients (mean age 58.6+-10.3 and 74% males) fulfilled entry criteria and BVS was successfully implanted in 96% of them. All patients were invited forclinical and computed tomographic angiographic control 1 year after BVS implantation. Restenosis was defined as GREATER-THAN OR EQUAL TO75% area stenosis within the scaffolded segment. Three events were potentially related to BVS: 1 in-st

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Circulation: Cardiovascular Interventions

ISSN

1941-7640

e-ISSN

—

Svazek periodika

8

Číslo periodika v rámci svazku

12

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

7

Strana od-do

"e002933"

Kód UT WoS článku

000366754200001

EID výsledku v databázi Scopus

—